Select Non Operating Income Net Other from 2010 to 2026
| SEM Stock | USD 15.90 0.26 1.66% |
Non Operating Income Net Other | First Reported 2011-06-30 | Previous Quarter 8.6 M | Current Value 10.5 M | Quarterly Volatility 12.7 M |
Check Select Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Select Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 136.7 M, Interest Expense of 151.7 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 0.44, Dividend Yield of 0.029 or PTB Ratio of 1.37. Select financial statements analysis is a perfect complement when working with Select Medical Valuation or Volatility modules.
Select | Non Operating Income Net Other | Build AI portfolio with Select Stock |
Evaluating Select Medical's Non Operating Income Net Other across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Select Medical Holdings's fundamental strength.
Latest Select Medical's Non Operating Income Net Other Growth Pattern
Below is the plot of the Non Operating Income Net Other of Select Medical Holdings over the last few years. It is Select Medical's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Select Medical's overall financial position and show how it may be relating to other accounts over time.
| Non Operating Income Net Other | 10 Years Trend |
|
Non Operating Income Net Other |
| Timeline |
Select Non Operating Income Net Other Regression Statistics
| Arithmetic Mean | 11,991,971 | |
| Geometric Mean | 20,433,837 | |
| Coefficient Of Variation | 219.75 | |
| Mean Deviation | 22,888,917 | |
| Median | 16,811,000 | |
| Standard Deviation | 26,352,228 | |
| Sample Variance | 694.4T | |
| Range | 78.7M | |
| R-Value | 0.64 | |
| Mean Square Error | 434.6T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 3,354,961 | |
| Total Sum of Squares | 11111T |
Select Non Operating Income Net Other History
About Select Medical Financial Statements
Select Medical investors utilize fundamental indicators, such as Non Operating Income Net Other, to predict how Select Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Operating Income Net Other | 30.4 M | 31.9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Select Medical Correlation against competitors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Health Care Providers & Services sector continue expanding? Could Select diversify its offerings? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Select Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.47) | Dividend Share 0.375 | Earnings Share 0.82 | Revenue Per Share | Quarterly Revenue Growth 0.072 |
Investors evaluate Select Medical Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Select Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Select Medical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Select Medical's market price signifies the transaction level at which participants voluntarily complete trades.